MNPR earnings: next report 2026-08-11, real EPS beat/miss history, analyst consensus Buy, P/E -54.34. Updated 2026-07-23.
Monopar Therapeutics (MNPR) Research Hub
Monopar Therapeutics (MNPR) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 110.26 USD (-1.89%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -54.34, market cap 0.75B. This hub links to the full technical, earnings and options research available for MNPR.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 110.26 USD (-1.89%) |
| 52-week range | 59.18 USD – 124.82 USD |
| Trend regime | Range |
| 14-day RSI | 42.7 (Bearish) |
| Trailing P/E | -54.34 |
| Market cap | 0.75B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-11 |
Available research for MNPR
Covered Call on MNPR: how it works, illustrative setup around the real 110.26 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on MNPR: how it works, illustrative setup around the real 110.26 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on MNPR: how it works, illustrative setup around the real 110.26 USD price, max profit/loss, breakeven and when to use it. Educational.
MNPR technical analysis: range, last 110.26 USD, RSI 42.7, 52w range 59.18 USD–124.82 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is MNPR in?
Monopar Therapeutics (MNPR) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is MNPR in an uptrend or downtrend?
As of 2026-09-11, MNPR is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is MNPR's trailing P/E ratio?
MNPR's trailing P/E is -54.34, with a market cap of 0.75B. See the earnings research page for full valuation detail.
When does MNPR next report earnings?
MNPR is next scheduled to report earnings on 2026-08-11, with a consensus EPS estimate of -0.67 USD.